United States · Platforms & data · TradingView

HC Wainwright & Co. upgrades Inovio Pharmaceuticals to Buy from Neutral, sets price target at $5

Published by TradingView · United States 1 d ago

HC Wainwright & Co. upgraded Inovio Pharmaceuticals to Buy from Neutral and set a price target of $5.The price target implies an upside of 730.0% from the Oct 30 close of…

Read the full article on TradingView Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tradingview.com)

Also worth reading

MarketBeat

BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 52-Week Low - Here's What Happened

Seeking Alpha

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

MarketWatch

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Investing.com

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

CNBC

Stock market after midterm elections: What S&P 500 history shows

TipRanks